Yi Qi Qing Re Gao formula ameliorates puromycin aminonucleoside-induced nephrosis by suppressing inflammation and apoptosis by unknown
Wen et al. BMC Complementary and Alternative Medicine  (2015) 15:155 
DOI 10.1186/s12906-015-0673-9RESEARCH ARTICLE Open AccessYi Qi Qing Re Gao formula ameliorates puromycin
aminonucleoside-induced nephrosis by suppressing
inflammation and apoptosis
Yumin Wen1,2,3, Yongli Zhan4, Huijie Liu5, Tingting Zhao2,3, Liping Yang4, Haojun Zhang2,3, Xi Dong2,3
and Ping Li2,3*Abstract
Background: Yi Qi Qing Re Gao (YQQRG) formula is a traditional Chinese herbal medicine used to treat chronic
nephritis. This study was designed to evaluate the underlying mechanism in the use of YQQRG formula to treat
nephrosis induced by puromycin aminonucleoside (PAN).
Methods: Thirty-six male Wistar rats were randomly divided into 3 groups of 12 rats each: a sham group, a
vehicle-treated PAN model group (PAN), and a group treated with YQQRG (PAN + YQQRG). The PAN model
was established by a single intravenous injection of PAN at a dose of 40 mg/kg body weight; rats in the
sham group received the same volume of saline. Twenty-four hour urinary protein was measured 0, 3, 5, 10, and
15 days after the injection. The rats were sacrificed on day 10 and day 15 and the serum lipid profile examined. The
renal cortex of each rat was stained with periodic acid–Schiff reagent and the pathologic alterations and ultrastructural
changes were examined by transmission electron microscopy. In situ cell apoptosis was detected by a terminal
deoxynucleotidyl transferase-mediated uridine 5′-triphosphate-biotin nick end-labeling (TUNEL) assay. Transcriptive
levels of inflammatory markers and molecules associated with apoptosis were detected by a real-time polymerase
chain reaction and expression of proteins was examined by either immunohistochemistry or Western blot analysis.
Results: YQQRG significantly decreased urinary protein level, and lowered serum lipid level. YQQRG also attenuated
histologic lesions in the rat kidneys. Activation of inflammatory markers was largely restored by the administration of
YQQRG. TUNEL assay showed that YQQRG decreased the number of apoptotic cells. Both mRNA and protein levels of
caspase-3 were significantly reduced in the group treated with YQQRG, whereas expression of the Bcl-2 protein
increased in the YQQRG group.
Conclusions: YQQRG alleviated kidney injury in PAN-treated rats, possibly through anti-inflammatory and anti-apoptotic
effects.
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Inflammation and apoptosis are typical pathological
features shared by a variety of kidney diseases, such
as glomerulosclerosis and tubulointerstitial fibrosis,
which consequentially induce renal failure. Prevention
and treatment of renal inflammation or apoptosis may
be a key issue in treating kidney disease.
There is a growing body of evidence indicating that
inflammation is a crucial contributor to the pathogenesis
of most kidney diseases [1]. The main mechanism of
inflammation in kidney damage is as follows [2].
Chemokines or adhesion molecules secreted by resident
renal cells attract circulating inflammatory cells and
induce infiltration of the inflammatory cells. Activated
inflammatory cells, such as macrophages and neutrophils,
are responsible for the production of various proinflam-
matory mediators. Proinflammatory cytokines have several
biologic effects, including direct cytotoxicity toward renal
cells, increased synthesis of other inflammatory molecules
and the triggering of cell apoptosis. Various macrophage
inhibition strategies have been used to successfully
treat kidney diseases in animal models [3]. Monocyte
chemoattractant protein (MCP-1), which triggers macro-
phage recruitment, has been found to be secreted by
tubular epithelial cells in both patients with proteinuria
and in proteinuric animal models.
Apoptosis is essential in the development of mammalian
kidneys and in the removal of excess glomerular cells in
the resolution of proliferative nephritis. However, severe
apoptosis caused by environmental and intrinsic stimuli
results in a loss of resident kidney cells and, thus conse-
quently, kidney injury [4]. Inflammation and apoptosis are
closely linked. Macrophages in the kidney are respon-
sible for apoptotic cell death induced by puromycin
aminonucleoside (PAN). Cytokine tumor necrosis factor α
(TNF-α) is a prominent stimulator of apoptosis. In chronic
proteinuric renal disease, inflammation and apoptosis are
implicated in glomerular sclerosis and tubular atrophy [5].
Yi Qi Qing Re Gao (YQQRG) formula, a traditional
Chinese herbal medicine, has been used to treat chronic
nephritis for over 2 decades in Guang’anmen Hospital,
Beijing. Our previous studies have found that YQQRG
decreases the excretion of urinary protein in patients with
chronic nephritic and in the rat model of adriamycin-
induced nephrosis [6, 7]. Treatment with serum containing
YQQRG, which was collected from YQQRG treated healthy
Wistar rats, ameliorated lipopolysaccharide-stimulated
rat mesangial cell proliferation in vitro (L Yang, et al.
unpublished data). Another study found that pretreatment
with YQQRG could protect the filtration barrier from
PAN-induced architectural damage [8]. Since lipopolysac-
charide is a powerful stimulus for inflammation, and
apoptosis is frequently involved in architectural damage,
we hypothesize the renoprotective effects of YQQRG maydue to its anti-inflammatory and anti-apoptotic actions.
The study reported here was designed to identify the
anti-inflammatory and anti-apoptotic effects of YQQRG
on nephrosis induced by PAN.
Methods
Herbal formulation and reagents
YQQRG formula is a natural herbal medicine formulated
based on the empirical experience of a Chinese medicine
expert. The ingredients of YQQRG formula and propor-
tions for each herb are: Astragalus membranaceus
(Fisch.) Bge 6.2 %, Atractylodes macrocephala Koidz
4.6 %, Saposhnikovia divaricata (Turcz.) Schischk
3.1 %, Lonicera japonica Thunb 6.2 %, Forsythia suspensa
(Thunb.) Vahl 6.2 %, Duchesnea indica (Jacks.) Focke
4.6 %, Oldenlandia diffusa (Willd.) Roxb 15.4 %, Poria
cocos (Schw.) Wolf 6.2 %, Alisma plantago-aquatica L
10.7 %, Leonurus japonicus Houtt 15.4 %, Imperata
cylindrica (L.) P. Beauv 15.4 %, and Dioscorea nipponica
Makino 6.2 %. All herbs were purchased from Kangmei
Pharmaceutical (Beijing, China). The herbs were com-
bined and decocted with water. The decoction was then
concentrated, ethanol precipitated, and finally sterilized.
The resulting preparation was creamy with each milliliter
equaling 4.5 g herbs. PAN and podocin antibody were
purchased from Sigma-Aldrich (St. Louis, MO, USA).
TNF-α, MCP-1, interleukin-1 beta (IL-1β) and CD68
antibodies were obtained from Santa Cruz Biotech (Santa
Cruz, CA, USA). TNFR1 antibody was purchased from
Abcam (Cambridge, MA, USA). iNOS and cleaved
caspase-3 antibodies were purchased from Cell Signaling
Technology (Beverly, MA, USA). Bcl-2 rabbit polyclonal
antibody was purchased from Bioworld Technology (St.
Louis Park, MN, USA). β-actin mouse monoclonal anti-
body, affinity-purified anti-mouse antibody and anti-rabbit
antibody were obtained from Jackson ImmunoResearch
(West Grove, PA, USA). A terminal deoxynucleotidyl
transferase-mediated uridine 5′-triphosphate-biotin nick
end-labeling (TUNEL) kit was purchased from Roche
Diagnostics GmbH (Penzberg, Germany).
Animals
Male Wistar rats weighing 90–100 g were purchased
from Beijing HFK Bio-Technology (Beijing, Certificate
No. SCXK 2009–0007). After 3 days of adaptive feeding,
the animals were randomly divided into 3 groups of 12 rats
each: a sham group; a vehicle-treated PAN model group
(PAN); and an YQQRG treatment group (PAN+YQQRG).
YQQRG was administered daily to the 12 YQQRG-treated
rats by gavage at a dosage of 4 g/kg body weight per day
for 1 week before PAN injection and 15 days after PAN
injection. The 12 PAN model animals received distilled
water. The PAN model was established by a single intra-
venous injection of PAN at a dose of 40 mg/kg body
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concentration of 1.33 mg/ml. The left internal jugular
vein was isolated and was ligated at the proximal end
with an intraperitoneal injection of 10 % chloral
hydrate (1 ml/300 g body weight). The jugular vein
was then punctured with an intravenous cannula con-
nected to a syringe filled with 3 ml of PAN solution. The
solution was injected over 5 min. The jugular vein
was ligated after the injection. The sham group received a
single injection of 3 ml of normal saline. All animals were
housed in a temperature-controlled environment at
22 ± 3 °C and 50 ± 10 % humidity under a 12-h light/dark
cycle and were allowed free access to tap water and
standard chow. The study protocol was approved by
the Ethics Committee of the China–Japan Friendship
Hospital and was performed in accordance with the
Guiding Principles for the Care and Use of Laboratory
Animals.
Serum and urine analysis
To determine urinary protein level, rats were placed into
metabolic cages 0, 3, 5, 10 and 15 days after injection of
PAN. Twenty-four hour urine samples were collected in
brown bottles and total urinary protein was measured
using the Bradford method [9]. Six rats in each group
were randomly sacrificed 10 and 15 days after the injec-
tion of PAN. Blood samples were collected from their
abdominal aorta for the determination of triglycerides
(TG) and low-density lipoprotein-cholesterol (LDL-C)
levels using an automatic biochemistry analyzer (Bayer,
Berlin, Germany).
Histologic examination
Both kidneys were removed after collection of the
blood sample. For examination by transmission electron
microscopy, the cortex from the upper pole of the right
kidney was cut into 1 mm3 sections, fixed by immersion
in 2.5 % glutaraldehyde, dehydrated with gradient acetone
and embedded with Epon 812 ethoxyline resin. The
samples were subsequently prepared as ultra-thin serial
sections and examined with a transmission electron micro-
scope (H-600, Hitachi, Tokyo, Japan). For the light micros-
copy examination, the kidneys were cut into transverse
sections and fixed in 10 % phosphate-buffered formalin
solution (pH 7.4) for over 24 h. After fixation, the sections
were embedded in paraffin and prepared as 3 μm slides for
periodic acid–Schiff (PAS) staining. Results were observed
using a BX-51 Research Microscope System and a DP70
Image Acquisition System (Olympus, Tokyo, Japan).
Real-time polymerase chain reaction
Total RNA was extracted from the kidney cortex of each
rat using TRIzol reagent (Invitrogen, Carlsbad CA,
USA). A total of 3 μg of RNA from each sample wasreverse-transcripted using a cDNA synthesis kit (Thermo
Fisher Scientific, Vilnius, Lithuania) following the manufac-
turer’s instructions. The target genes were amplified in an
ABI 7500 real-time PCR system (Life Technologies, Grand
Island, NY, USA). Reactions were carried out in 96-well
plates with 25 μl volumes containing 30 ng of cDNA, 200
nM of each primer and 12.5 μl 2× SYBR Green Master
Mix Reagent. Each reaction was performed in triplicate.
ß-Actin was used as an internal control. The primers
were generated using Oligo 7 software (Molecular Biology
Insights, Colorado Springs, CO, USA) (Table 1). Data were
analyzed by the 2−ΔΔCT method [10].
Immunohistochemistry
Paraffin sections were prepared by dewaxing and rehydrat-
ing. Endogenous peroxidase activity was suppressed by
incubating the section in 3 % H2O2 for 10 min. The anti-
gens were then demasked by heat-induced epitope retrieval
in either pH 6 citrate buffer or pH 9 Tris–EDTA buffer
according to the manufacturer’s instructions for each
antibody. The sections were incubated overnight at 4 °C
with primary antibodies diluted in antibody dilution buffer.
After gently washing with Tris-buffered saline (TBS), the
sections were incubated with horseradish peroxidase en-
zyme labeled secondary antibodies at 4 °C for 30 min. The
reaction was visualized by adding DAB substrate solution
and counterstaining with hematoxylin. Image-Pro Plus 6.0
image analysis software (Media Cybernetics, Warrendale,
PA, USA) was used to semi-quantify the results.
TUNEL assay
Apoptosis was detected in situ using a TUNEL kit
according to the manufacturer’s instructions. After dewax-
ing and rehydrating, paraffin sections were treated with
Wen et al. BMC Complementary and Alternative Medicine  (2015) 15:155 Page 4 of 14protease (20 μg/ml) for 30 min at 37 °C and then incubated
with 50 μl of TUNEL reaction mixture for 30 min at 37 °C
in the dark. This was followed by treatment with 50 μl of
converter-POD solution for 30 min at 37 °C and incuba-
tion with DAB substrate solution before analysis by light
microscopy. The nuclei of apoptotic cells were stained
dark brown.Western blotting
Kidney cortices were isolated and frozen in liquid
nitrogen. A total of 40 μg protein per lane was separated
on 12 % SDS-PAGE gel and electrophoretically trans-
ferred to PVDF membranes. The membranes were
incubated overnight at 4 °C with the relevant primary
antibodies, followed by incubation with appropriate
secondary antibodies at room temperature for 1 h. After
washing 3 times with TBS, the bands were visualized by
ECL Western blotting detection reagents (Engreen Bio-
system, Beijing, China) and analyzed semi-quantitatively
by the Image J software (National Institutes of Health,
Bethesda, MD, USA).Statistical analysis
Results are expressed as mean ± SD. Multiple comparisons
among groups were performed using one-way analysis of
variance followed by the Student–Newman–Keuls test.
Differences with P < 0.05 were considered significant.Results
Effect of YQQRG proteinuria and serum lipid disorder
As shown in Table 2, before the injection of PAN, the
total urinary protein in each group was below 2 mg/24 h.
Proteinuria level in the PAN group was increased to
110.4 mg/24 h five days after the injection of PAN
(P < 0.01). Proteinuria level in the PAN group peaked
at 338.2 mg/24 h on day 10 (P < 0.01) and decreased to
226.84 mg/24 h a day 15 (P < 0.01), whereas Proteinuria
level in the sham group remained unchanged. Treatment
with YQQRG significantly decreased Proteinuria level
on days 10 and 15 (P < 0.05). In addition, the PAN
group exhibited an increase in TG and LDL-C levels,
which are typical manifestations of nephrotic syn-
drome. YQQRG persistently decreased the levels of
TG and LDL-C (Fig. 1).Table 2 Effects of YQQRG on urinary protein levels (mg/24 h)
Day 0 Day 3 Da
Sham 1.01 ± 0.16 1.38 ± 0.18 2.8
PAN 1.25 ± 0.60 2.36 ± 0.56 110
PAN + YQQRG 1.26 ± 0.51 2.99 ± 1.31 134
Data are presented as mean ± SD. **P < 0.01 compared with sham group. #P < 0.05,Influences of YQQRG renal morphology
Transmission electron microscopy revealed obvious
architectural abnormalities of the filtration barrier in the
PAN group (Fig. 2). The sham group presented a normal
structure with a thin and regular arrangement of the
foot processes. However, diffuse podocyte foot process
effacement along with prominent endothelial cell swelling
were observed in the PAN group at each time point.
Treatment with YQQRG markedly reduced the severity of
foot process effacement compared with the PAN group.
PAS staining did not reveal abnormal glomerular struc-
tures in any of the groups (data not shown). In parallel
with the severity of proteinuria, the PAN group showed
persistent protein casts in the distal tubules and collecting
tubules on days 10 and 15, whereas the sham group
exhibited a normal structure (Fig. 3). Treatment with
YQQRG restored this change.
Effect of YQQRG on podocyte injury
To further verify the successful establishment of the PAN
model in this study and observe the effect of YQQRG on
podocyte injury, the expression of podocin was examined
by Western Blot. Podocin is specifically localized to the
podocyte foot processes, which function to maintain the
glomerular filtration permeability. In PAN induced neph-
rosis, podocin expression is markedly decreased due to the
severe podocyte injury [11]. Podocin expression was largely
decreased in the PAN model group at both time points,
while it was upregulated by YQQRG treatment (Fig. 4).
Action of YQQRG on the activation of inflammatory
markers in the kidney
To observe the anti-inflammatory effects of treatment
with YQQRG, changes in inflammatory mediators were
examined in this model. In agreement with previously
published reports [12–14], inflammatory markers involved
in the PAN model, including cytokine TNF-α (Fig. 5) and
its receptor TNFR1 (Fig. 6), IL-1β (Fig. 7) and chemokine
MCP-1 (Fig. 8), were detected by immunohistochemistry
and real-time PCR. Macrophage infiltration was evaluated
by immunohistochemistry staining of CD68 (Fig. 9). These
markers of expression were all upregulated at both time
points after PAN injection in the PAN group. Most of the
mediators were localized to the tubules and interstitium,
except for the distribution pattern of TNFR1 in both
tubules and glomeruli. Treatment with YQQRG resultedy 5 Day 10 Day 15
9 ± 1.19 5.32 ± 1.70 6.52 ± 2.55
.40 ± 48.85** 338.20 ± 93.24** 226.84 ± 87.63**
.85 ± 57.13** 238.02 ± 55.78**## 170.87 ± 35.77**#
##P < 0.01 compared with PAN group
Fig. 1 Serum lipid changes at indicated time points after the injection of PAN. A Triglyceride levels. B LDL-C levels. Rats in the PAN + YQ group
received a daily oral gavage of YQQRG. Rats in the sham and PAN groups received the same volume of vehicle (distilled water). *P < 0.05 and
**P < 0.01 compared with the sham group; #P < 0.05, ##P < 0.01 compared with the PAN model group. LDL-C, low-density lipoprotein-cholesterol
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IL-1β and CD68 after injection with PAN, whereas TNFR1
and MCP-1 were decreased on day 15. In terms of the
level of transcription, significant decreases as a result of
YQQRG treatment were found on day 15.
Action of YQQRG on renal iNOS expression
Inducible nitric oxide Synthase (iNOS) is usually acti-
vated by inflammation to produce excessive reactiveFig. 2 Ultrastructural measurement of glomeruli by electron microscopy. R
in the sham and PNA groups received the same volume of vehicle (distilled w
back arrow, podocyte foot process in the sham panel; dotted arrow, diffuse fo
cell swelling in PAN paneloxygen species (ROS), which can greatly damage cells.
Physiologically, iNOS produces the vasoactive substance
nitric oxide (NO), which is essential for blood pressure
control and the kidney development. In order to evaluate
the action of YQQRG on inflammation induced oxidative
stress, this study examine the renal iNOS expression by
immunohistochemistry. iNOS expressions in both the
PAN group and PAN+ YQQRG group did not show
statically significant difference with the sham group,ats in the PAN + YQ group received a daily oral gavage of YQQRG. Rats
ater). 10D, 10 days after PAN injection; 15D, 15 days after PAN injection;
ot process effacement in PAN panel; arrow head, segmental endothelial
Fig. 3 Representative morphological changes in tubules (periodic acid–Schiff staining). Rats in the PAN + YQ group received a daily oral gavage
of YQQRG. Rats in the sham or PNA groups received the same volume of vehicle (distilled water). 10D, 10 days after PAN injection; 15D, 15 days
after PAN injection. The protein cast in the distal tubules and collecting tubules is indicated by a black star in the PAN panel
Fig. 4 Effect of YQQRG on podocin expression. Podocin expression is evaluated by Western blot. The upper panel indicates the original band
observed by Western blot. The lower panel displays semi-quantitative results. Rats in the PAN + YQ group received a daily oral gavage of YQQRG.
Rats in the sham and PNA groups received the same volume of vehicle (distilled water). 10D, 10 days after PAN injection; 15D, 15 days after PAN
injection. Data are presented as mean ± SD values for each group of 3 animals. **P < 0.01 compared to sham group, respectively.
#P < 0.05 and ##P < 0.01 compared with PAN group, respectively.
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Fig. 5 Effect of YQQRG treatment on expression of TNF-α in the kidney. Expression of TNF-α protein was determined by immunohistochemistry
staining and relative semi-quantified assay (A). Transcription level of TNF-α was examined by real-time PCR at 10 days (B) and 15 days (C) after
injection of PAN. Rats in the PAN + YQ group received a daily oral gavage of YQQRG. Rats in the sham and PNA groups received the same
volume of vehicle (distilled water). 10D, 10 days after PAN injection; 15D, 15 days after PAN injection. Data are presented as mean ± SD values
for each group of 3 animals. *P < 0.05 and **P < 0.01 compared to sham group, respectively. #P < 0.05 and ##P < 0.01 compared with PAN group,
respectively. (magnification × 200, scale bar = 100 μm)
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in iNOS expression (Fig. 10).
Effect of YQQRG on TUNEL-positive apoptosis cells
Apoptotic cells were rarely present in the sham
group, whereas the PAN group showed a significant
increase in glomerular and tubular apoptosis at each
time point (Fig. 11). Histologic observations revealed
that the apoptotic cells were resident cells, mainly
podocytes and endothelial cells in the glomeruli and
epithelial cells in the proximal and distal tubules.
Treatment with YQQRG decreased the number of
apoptotic cells in both the glomeruli and tubules.
Effects of treatment with YQQRG on the renal expression
of the apoptosis-associated proteins caspase-3 and Bcl-2
Western blot quantification showed a potent increase in
expression of cleaved caspase-3 protein in the PAN group
compared with the sham group (P < 0.01). Treatment withYQQRG decreased expression of cleaved caspase-3 at
both time points (Fig. 12A). Injection with PAN signifi-
cantly decreased level of Bcl-2 protein at both time points
(P < 0.05). Treatment with YQQRG increased its expres-
sion, but statistical significance was only found on day 10
(P < 0.05) (Fig. 12B). In a similar manner to the expression
of protein, real-time-PCR analysis revealed that mRNA
expression of caspase-3 increased persistently after injec-
tion of PAN in the PAN group compared with the sham
group (P < 0.01). Treatment with YQQRG significantly
decreased its expression on day 10 (P < 0.01) and on day
15 (P < 0.05) after injection with PAN compared with the
model group (Fig 12C). However, mRNA expression of
Bcl-2 did not change after injection with PAN (Fig 12D).
Discussion
PAN-induced nephrosis is a well-established animal
model that mimics human minimal change disease, which
is characterized by massive proteinuria and hyperlipemia
Fig. 6 Effect of YQQRG treatment on renal expression of TNFR1. TNFR1 was detected by immunohistochemistry (A) and real-time PCR (B and C).
Rats in the PAN + YQ group received a daily oral gavage of YQQRG. Rats in the sham and PNA groups received the same volume of vehicle
(distilled water). 10D, 10 days after PAN injection; 15D, 15 days after PAN injection. Data are presented as mean ± SD values for each group of
3 animals. *P < 0.05 and **P < 0.01 compared with the sham group. #P < 0.05 compared with PAN group, respectively. (magnification × 200,
scale bar = 100 μm)
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about 2 weeks, after which the kidneys undergo self-
healin. The mechanisms of recovery are currently
unknown. Typical histologic changes in this model
are abnormalities of the glomerular epithelial cells
and endothelial cells. Numerous studies have confirmed
that nephrotic-range proteinuria is accompanied by
kidney lesions, increased inflammation and apoptosis,
which indicates that inflammation together with apoptosis
may be the underlying mechanism of these changes.
In the present study, we found that treatment with
YQQRG significantly decreased 24-h urinary protein levels
and improved serum lipid disorder in PAN-induced neph-
rosis, providing evidence that YQQRG may ameliorate
nephrotic syndrome in vivo. Morphologic study revealed
that treatment with YQQRG could preserve the filtration
barrier architecture and decrease the amount of protein
cast in correlation with the inhibition of proteinuria.
At the same time, YQQRG could restore the expression of
podocin in the podocyte. As inflammation and apoptosispromote progression of kidney injuries in this model, we
hypothesize that the renoprotective function of YQQRG
may be at least partly a result of its anti-inflammatory and
anti- apoptotic effects.
As TNF-α is a strong mediator of inflammation, this
study focused on the changes in TNF-α and its receptor
TNFR1. TNF-α is typically synthesized by monocytes/
macrophages, whereas in the kidney various intrinsic cells,
including tubular epithelial cells, podocytes, mesangial
cells and endothelial cells, could be the original source of
TNF-α synthesis. The pathophysiologic role of TNF-α
in mediating kidney disease has been well defined by
numerous studies. Increased circulatory and urinary
levels of TNF-α have been found to be independently
associated with increased proteinuria in patients with
diabetic nephropathy. Renal TNF-α accumulation is also
involved in increasing the permeability of albumin. In
accordance with the level of urinary protein, TNF-α
production in the kidney is largely increased in the
acute phase and gradually decreased 2 weeks after the
Fig. 7 Effect of YQQRG treatment on renal expression of IL-1β. The inflammatory cytokine IL-1β was observed by immunohistochemistry assay
(A), along with its gene transcription examined by real-time PCR in the renal cortex (B and C). Rats in the PAN + YQ group received daily oral
gavage of YQQRG. Rats in the sham and PNA groups received the same volume of vehicle (distilled water). 10D, 10 days after PAN injection;
15D, 15 days after PAN injection. Data are presented as mean ± SD values for each group of 3 animals. *P < 0.05 and **P < 0.01 compared to
sham group, respectively. #P < 0.05 and ##P < 0.01 compared to PAN group, respectively. (magnification × 200, scale bar = 100 μm)
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renal cells and its toxicity can be successfully abolished by
anti-TNF antibodies [12]. TNF-α interacts with its recep-
tors TNFR1 and TNFR2 to recruit inflammatory cells and
initiate apoptosis. In this study, we examined the signaling
regulatory effect of YQQRG on TNF.
A significant positive correlation has been reported
in the PAN model between the severity of interstitial
nephritis, as determined by increased CD68 positive
macrophages, MCP-1 and IL-1β, and the degree of
proteinuria. This study showed that YQQRG decreased
the infiltration of macrophages in the tubular interstitium.
Other inflammatory cytokine and chemokine activations
involved in PAN-induced nephrosis, including IL-1β and
MCP-1, were abolished by treatment with YQQRG.
The role of iNOS and NO in PAN model remains
to be elucidated. There are contradictory reports in
the literature on iNOS expression in the PAN model.
Most studies have demonstrated that ROS production
is upregulated in PNA-treated animals [16, 17]. However,Ni et al. [18] observed that iNOS as well as NO metabo-
lites were decreased in PAN-treated rats, concluding the
decreased iNOS was secondary to increased proteinuria.
In the current study, immunohistochemistry indicated
iNOS was localized to the periglomerular tubules in
the kidney cortex, consistent with the finding reported by
Walker et al. [19]. We observed that the PAN treated
group did not differ from the sham group in iNOS expres-
sion, and YQQRG treatment did not influence iNOS
expression.
Podocyte apoptosis is largely involved in PAN-induced
nephrosis and the progression of focal segmental glo-
merulosclerosis [20]; PAN causes apoptosis in cultured
podocytes [21]. In our previous study, we found that
pretreatment with YQQRG inhibited reduction of
podocyte-specific molecular nephrin, podocin and CD-2AP
in the PAN model [8]. In this study, we found signifi-
cant cell apoptosis in the podocytes and tubules, which
treatment with YQQRG could reduce. Unlike its direct
injury to glomeruli, PAN is not toxic towards tubular cells
Fig. 8 Effect of YQQRG treatment on renal expression of MCP-1. The chemokine MCP-1 was assessed by immunohistochemistry (A) and real-time
PCR (B and C). Rats in the PAN + YQ group received daily oral gavage of YQQRG. Rats in the sham and PNA groups received the same volume of
vehicle (distilled water). 10D, 10 days after PAN injection; 15D, 15 days after PAN injection. Data are presented as mean ± SD values for each group
of three animals. **P < 0.01 compared to sham group, respectively. #P < 0.05 and ##P < 0.01 compared to PAN group, respectively. (magnification ×
200, scale bar = 100 μm)
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attributed to the impact of proteinuria and lipid toxicity
[23]. Albumin bound to fatty acids in urine is reabsorbed
into the proximal tubular epithelial cells and results in
apoptosis and tubular damage [24]. As a major character-
istic of the PAN nephrosis model, increased serum lipids
have been recognized to be a powerful stimulus of cellular
apoptosis [25]. Treatment with YQQRG may decrease
serum levels of TG and LDL-C. We therefore deduced
that the reduction of apoptosis by treatment with
YQQRG may be partially from its lipid lowering function.
Treatment with YQQRG may inhibit tubular epithelial cell
apoptosis by regulating lipid disorders and decreasing
urinary excretion of albumin.
To further clarify the mechanism of its anti-apoptotic
action, we examined the influence of YQQRG on the
expression of two major apoptosis-regulating factors:
caspase-3 and Bcl-2. As a major executor of apoptosis,
caspase-3 is considered to be the final downstream
protein required for apoptosis [26]. Once activated, cleavedcaspase-3 mediates cleavage of various substrates to trigger
apoptosis. Bcl-2 is a pivotal anti-apoptotic member of
the Bcl family. The major contribution of Bcl-2 is in
maintaining cellular calcium homeostasis to inhibit
activation of calpain and, thus to suppress the cleavage of
caspase-4/12 in the outer membrane of the endoplasmic
reticulum [27]. In addition, Bcl-2 has the ability to form
heterodimers with the pro-apoptotic members of the Bcl
family Bax/Bak, resulting in a decrease in pro-apoptotic
ability and promotion of cell survival [28]. We observed
that YQQRG could downregulate expression of caspase-3
at both the transcriptional and translational levels.
Treatment with YQQRG increased expression of Bcl-2
protein. In this way, YQQRG may act as an efficient
anti-apoptotic agent.
Several ingredients in YQQRG have anti-inflammatory
and anti-apoptotic effects. Astragalus membranaceus is
the major ingredient of YQQRG and there is abundant
evidence that its active component, astragaloside IV,
has a prominent anti-inflammatory effect through the
Fig. 9 Effect of YQQRG treatment on renal macrophage infiltration. Macrophages were assessed as CD68-positive cells in the kidney. Quantification
results are shown for the number of CD68-positive cells. Rats in the PAN + YQ group received daily oral gavage of YQQRG. Rats in the sham and PNA
groups received the same volume of vehicle (distilled water). 10D, 10 days after PAN injection; 15D, 15 days after PAN injection. Data are presented as
mean ± SD values for each group of three animals. **P < 0.01 compared to sham group, respectively. ##P < 0.01 compared to PAN group, respectively.
(magnification × 200, scale bar = 100 μm)
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tion and NF-κB signaling pathways [29, 30]. Other
components in YQQRG, including Lonicera japonica
[31], Forsythia suspense [32, 33], Duchesnea [34] and
Oldenlandia diffusa [35] exhibit potential anti-inflammatory
activities. The anti-apoptotic effects of astragalosidesFig. 10 Action of YQQRG on renal iNOS expression. Renal iNOS expression
received a daily oral gavage of YQQRG. Rats in the sham and PNA groups
after PAN injection; 15D, 15 days after PAN injection. Data are presented as
scale bar = 100 μm)have been addressed by other researchers [36, 37],
and administration of astragalosides may inhibit high
glucose-induced renal tubular epithelial cell apoptosis
[38]. Chlorogenic acid, the main component of Lonicera
japonica, may protect cells against apoptosis by attenuating
caspase-3 activation [39]. Luteolin in Lonicera japonicawas assessed by immunohistochemistry. Rats in the PAN + YQ group
received the same volume of vehicle (distilled water). 10D, 10 days
mean ± SD values for each group of 3 animals. (magnification × 200,
Fig. 11 In situ cell apoptosis detected by TUNEL assay. Rats in the PAN + YQ group received a daily oral gavage of YQQRG. Rats in the sham and
PNA groups received the same volume of vehicle (distilled water). 10D, 10 days after PAN injection; 15D, 15 days after PAN injection. Apoptotic
cells (arrow) are illustrated in the PAN panel. (magnification × 400, scale bar = 50 μm)
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to ameliorate cisplatin-induced nephrotoxicity [40].
Leonurine in Leonurus japonicus may inhibit apoptosisthrough the mitochondria pathway [41]. Anemonin in
Poria cocos appears to significantly decrease TUNEL-
positive cells in rats with ischemia and reperfusion
Fig. 12 Effect of YQQRG treatment on the apoptosis-associated molecules caspase-3 and Bcl-2 expression. Protein expression of cleaved caspase-3
(A) and Bcl-2 (B) were examined by Western blot analysis. mRNA expression of caspase-3 (C) and Bcl-2 (D) were assessed by real-time PCR. Rats in
the PAN + YQ group received a daily oral gavage of YQQRG. Rats in the sham and PNA groups received the same volume of vehicle (distilled water).
10D, 10 days after PAN injection; 15D, 15 days after PAN injection. Data are presented as mean ± SD values for each group of three animals.*P < 0.05,
**P < 0.01 compared with sham group; #P < 0.05, ##P < 0.01 compared with PAN group
Wen et al. BMC Complementary and Alternative Medicine  (2015) 15:155 Page 13 of 14injury [36]. Nevertheless, as YQQRG is comprised of
several herbal medicines and the actions of a single
compound may be very different when combined in the
formula, further studies are necessary to investigate the
effects of YQQRG as a whole.Conclusions
The present study demonstrates that YQQRG might be
a novel therapeutic agent in the treatment of nephrosis.
Ameliorating renal inflammation and protecting resi-
dent renal cells from apoptosis is a possible underlying
mechanism by which YQQRG inhibits PAN-associated
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